News Daily News Oral GLP-1 Drug Yields 12% Weight Loss in Nondiabetic Patients With Obesity L.A. McKeown August 07, 2025
News Daily News Physical Activity Ebbs, Flows Over a Lifetime but Rarely Rebounds After CVD Caitlin E. Cox July 23, 2025
News Daily News PRAGUE-25: Ablation Improves Rhythm Control, but Don’t Discount Lifestyle Changes Todd Neale July 14, 2025
News Daily News Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC Michael O'Riordan June 25, 2025
News Daily News Weight-Loss Drug MariTide Gains Momentum in Phase II Trial Caitlin E. Cox June 25, 2025
News Daily News AHA Offers a Primer on Alcohol’s CV Impact, Areas of Uncertainty Caitlin E. Cox June 13, 2025
News Conference News ESOC 2025 Simple, Phone-Based Strategy Improves BP Control in Stroke Survivors Todd Neale June 02, 2025
News Conference News European Congress on Obesity 2025 Obesity-Related Cancer Rates No Different With GLP-1s vs Bariatric Surgery Michael O'Riordan May 14, 2025
News Conference News European Congress on Obesity 2025 SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly Michael O'Riordan May 14, 2025
News Conference News European Congress on Obesity 2025 App-Based Support Aids Weight Loss With Semaglutide, Studies Show Michael O'Riordan May 13, 2025
News Conference News European Congress on Obesity 2025 Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5 Michael O'Riordan May 12, 2025
News Conference News SCAI 2025 Pain in the Neck? Operators Seek Solutions to Lead’s Weighty Toll L.A. McKeown May 05, 2025
News Daily News Donor Hearts Fare Better With Novel Method After Circulatory Death Michael O'Riordan May 01, 2025
News Conference News HRS 2025 GLP-1 Drugs May Have Role in Secondary Prevention of AF Todd Neale April 28, 2025
News Daily News High BMI Before Pregnancy Tied to Greater CVD Risk Later in Life L.A. McKeown April 14, 2025
News Conference News ACC 2025 FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints L.A. McKeown April 03, 2025
News Conference News ACC 2025 SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes Michael O'Riordan March 29, 2025